New study lets myasthenia gravis patients rate their own symptoms on a new drug

This study follows 50 adults with generalized myasthenia gravis who are taking Rozanolixizumab. Researchers want to see how the drug affects symptoms like fatigue and muscle weakness from the patient's own point of view. Participants will fill out a special questionnaire over 9 months to track their experience. The goal is to better understand how well the treatment works in everyday life.